Brookdale Senior Living Company Profile (NYSE:BKD)

Brookdale Senior Living trades on the New York Stock Exchange (NYSE) under the ticker symbol "BKD."

Brookdale Senior Living Inc. (NYSE:BKD) issued its quarterly earnings data on Monday, August, 7th. The company reported ($0.23) EPS for the quarter, missing the Zacks' consensus estimate of $0.56 by $0.79. The company had revenue of $1.19 billion for the quarter, compared to analyst estimates of $1.14 billion. Brookdale Senior Living had a negative net margin of 10.14% and a positive return on equity of 6.00%. The business's revenue was down 5.7% on a year-over-year basis. During the same period in the prior year, the company posted ($0.19) EPS. View Brookdale Senior Living's Earnings History.

Brookdale Senior Living is scheduled to release their next quarterly earnings announcement on Tuesday, November, 7th 2017. View Earnings Estimates for Brookdale Senior Living.

5 brokerages have issued 12 month price targets for Brookdale Senior Living's stock. Their forecasts range from $12.00 to $19.50. On average, they expect Brookdale Senior Living's stock price to reach $16.60 in the next twelve months. View Analyst Ratings for Brookdale Senior Living.

Here are some recent quotes from research analysts about Brookdale Senior Living stock:

• 1. According to Zacks Investment Research, "Brookdale Senior Living Inc. is a leading owner and operator of senior living facilities throughout the United States. The Company is committed to providing an exceptional living experience through properties that are designed, purpose-built and operated to provide the highest-quality service, care and living accommodations for residents. The Company owns and operates independent, assisted and dementia-care facilities. " (8/10/2017)
• 2. Jefferies Group LLC analysts commented, "We're upgrading BKD to Buy as its risk-reward has improved after its recent pullback. While we're putting a >50% probability that BKD's ongoing sale process results in a deal, we think shares can reach $14.50 even without a takeout if BKD achieves its FCF guidance. That said, combining the Board's recognition of NT fundamental challenges & the compelling LT demographics-driven outlook for senior housing makes a sale of BKD (at $17-$20) more likely, in our view." (3/27/2017)

Some companies that are related to Brookdale Senior Living include FibroGen (FGEN), Acadia Healthcare Company (ACHC), Mednax (MD), Clovis Oncology (CLVS), Integra LifeSciences Holdings Corporation (IART), Hikma Pharmaceuticals Plc (HKMPF), Opko Health (OPK), Molina Healthcare (MOH), ICU Medical (ICUI), Patterson Companies (PDCO), Cantel Medical Corp. (CMD), Nektar Therapeutics (NKTR), Mallinckrodt PLC (MNK), BeiGene (BGNE), LivaNova PLC (LIVN), Insulet Corporation (PODD), Evotec AG (EVTCY) and Agios Pharmaceuticals (AGIO).

Brookdale Senior Living's management team includes the folowing people:

• Daniel A. Decker, Executive Chairman of the Board
• Thomas Andrew Smith, President, Chief Executive Officer, Director
• Lucinda M. Baier, Chief Financial Officer
• Labeed S. Diab, Chief Operating Officer
• George Thomas Hicks, Executive Vice President - Finance, Treasurer
• Bryan D. Richardson, Executive Vice President, Chief Administrative Officer
• Cedric T. Coco, Executive Vice President, Chief People Officer
• H. Todd Kaestner, Executive Vice President - Corporate Development
• Mary Sue Patchett, Executive Vice President - Community and Field Operations
• Marcus E. Bromley, Independent Director

Brookdale Senior Living's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include Glenview Capital Management LLC (8.19%), Vanguard Group Inc. (8.02%), Dimensional Fund Advisors LP (5.31%), Capital World Investors (3.44%), New South Capital Management Inc. (3.27%) and Paulson & CO. Inc. (2.68%). Company insiders that own Brookdale Senior Living stock include Daniel A Decker, Frank M Bumstead, George T Hicks, Jackie M Clegg, Labeed S Diab, Lucinda M Baier and Thomas Andrew Smith. View Institutional Ownership Trends for Brookdale Senior Living.

Brookdale Senior Living's stock was sold by a variety of institutional investors in the last quarter, including Brookfield Asset Management Inc., First Trust Advisors LP, Land & Buildings Investment Management LLC, Real Estate Management Services LLC, Teachers Advisors LLC, Edmond DE Rothschild Holding S.A., Vanguard Group Inc. and Marshall Wace North America L.P.. View Insider Buying and Selling for Brookdale Senior Living.

Brookdale Senior Living's stock was bought by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP, Macquarie Group Ltd., Cibc World Markets Corp, Employees Retirement System of Texas, Glenview Capital Management LLC, Blue Jay Capital Management LLC, Prudential Financial Inc. and Farallon Capital Management LLC. Company insiders that have bought Brookdale Senior Living stock in the last two years include Daniel A Decker, Frank M Bumstead, George T Hicks, Jackie M Clegg, Labeed S Diab, Lucinda M Baier and Thomas Andrew Smith. View Insider Buying and Selling for Brookdale Senior Living.

Shares of Brookdale Senior Living can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Brookdale Senior Living stock can currently be purchased for approximately $10.90.